Personalized periodontal treatment for the tobacco- and alcohol-using patient.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanisms and clinical management without systematic review methodology
PubMed 30198132 · doi:10.1111/prd.12229
What was done
This narrative review synthesized the microbiological, host/inflammatory response, and genetic profiles associated with tobacco use and heavy alcohol consumption to outline a framework for personalized periodontal therapy and cessation interventions across various tobacco forms (including cigarettes, cigars, pipes, smokeless tobacco, and e-cigarettes).
What was found
The abstract reports no numerical data, effect sizes, or statistical metrics. Qualitatively, it highlights tobacco use as a major preventable risk factor that impairs outcomes for periodontal therapy and dental implants, notes that heavy alcohol intake exacerbates these harms, and states that tailored cessation programs can mitigate these adverse effects.
Why it matters
It outlines practical clinical considerations for dentists and periodontists to combine motivational and pharmacological cessation strategies with tailored periodontal care for patients using tobacco and alcohol.
Limits
As a narrative review, it presents no primary data, systematic search criteria, or quantitative meta-analytic pooling. Specific effect sizes, study populations, and quantitative intervention outcomes are absent from the abstract.
Cited by
- supports Oral nicotine use contributes to the development or worsening of gum disease.